A proposal for staging COVID‐19 coagulopathy
Jecko Thachil, Mary Cushman, Alok Srivastava, Pantep Angchaisuksiri
Abstract
Coronavirus disease 2019 (COVID-19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID-19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.
Topics & Concepts
CoagulopathyCoronavirus disease 2019 (COVID-19)Intensive care medicineMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusPandemicDiseaseSurgeryVirologyPathologyInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsVenous Thromboembolism Diagnosis and Management